Transient Receptor Potential (TRP) Therapeutics—
A New Approach to Pain Treatment
Unlocking the TRP
Non-Opioid, Non-Addictive, Pain Therapeutics.
Algomedix is developing novel Transient Receptor Potential (TRP) therapeutics to treat serious unmet medical needs including acute and chronic pain and kidney disease.
Multiple Targets. Multiple Opportunities.
Chronic Pain, Acute Pain, Kidney Disease, Asthma, Pulmonary Hypertension, Cough, COPD, Migraine, Cough, Ocular Pain, Ocular irritation, Nephrosis, Diabetic Neuropathy, Cardiac Hypertrophy, Bladder Hyperactivity, Painful Bladder Syndrome, Interstitial Cystitis